Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3112)
All Articles published online
|
Jun 28, 2011 (publication date) through Apr 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yeh CN, Lin KJ, Chen TW, Wu RC, Tsao LC, Chen YT, Weng WH, Chen MF. Characterization of a novel rat cholangiocarcinoma cell culture model-CGCCA. World J Gastroenterol 2011; 17(24): 2924-2932 [PMID: 21734803 DOI: 10.3748/wjg.v17.i24.2924] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i24/2924.htm |
| Number | Citing Articles |
| 1 |
Ming-Huang Chen, Kun-Chun Chiang, Chi-Tung Cheng, Shih-Chiang Huang, Yeng-Yang Chen, Tsung-Wen Chen, Ta-Sen Yeh, Yi-Yin Jan, Hsi-Ming Wang, Jiang-Jie Weng, Peter Mu-Hsin Chang, Chun-Yu Liu, Chung-Pin Li, Yee Chao, Ming-Han Chen, Chi-Ying F. Huang, Chun-Nan Yeh. Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma. Oncotarget 2014; 5(9): 2372 doi: 10.18632/oncotarget.1706
|
| 2 |
Chun‐Nan Yeh, Ming‐Huang Chen, Yu‐Chan Chang, Ren‐Chin Wu, Lee‐Cheng Tsao, Shang‐Yu Wang, Chi‐Tung Cheng, Kun‐Chun Chiang, Tsung‐Wen Chen, Michael Hsiao, Wen‐Hui Weng. Over‐expression of TNNI3K is associated with early‐stage carcinogenesis of cholangiocarcinoma. Molecular Carcinogenesis 2019; 58(2): 270 doi: 10.1002/mc.22925
|
| 3 |
Susana Meles, Filomena Adega, João Castro, Raquel Chaves. Cytogenetic Assessment of the Rat Cell Line CLS-ACI-1: An in vitro Cell Model for <b><i>Mycn</i></b> Overexpression. Cytogenetic and Genome Research 2015; 146(4): 285 doi: 10.1159/000441374
|
| 4 |
Chun-Nan Yeh, Chi-Wei Chang, Yi-Hsiu Chung, Shi-Wei Tien, Yong-Ren Chen, Tsung-Wen Chen, Ying-Cheng Huang, Hsin-Ell Wang, You-Cheng Chou, Ming-Huang Chen, Kun-Chun Chiang, Wen-Sheng Huang, Chung-Shan Yu. Synthesis and characterization of boron fenbufen and its F-18 labeled homolog for boron neutron capture therapy of COX-2 overexpressed cholangiocarcinoma. European Journal of Pharmaceutical Sciences 2017; 107: 217 doi: 10.1016/j.ejps.2017.07.019
|
| 5 |
Ming-Huang Chen, Chueh-Chuan Yen, Chi-Tung Cheng, Ren-Chin Wu, Shih-Chiang Huang, Chung-Shan Yu, Yi-Hsiu Chung, Chun-Yu Liu, Peter Mu-Hsin Chang, Yee Chao, Ming-Han Chen, Yu-Fen Chen, Kun-Chun Chiang, Ta-Sen Yeh, Tzu Chi Chen, Chi-Ying F. Huang, Chun-Nan Yeh. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. Oncotarget 2015; 6(27): 23594 doi: 10.18632/oncotarget.4335
|
| 6 |
Ming‐Huang Chen, Kun‐Ju Lin, Wu‐Lung R. Yang, Ya‐Wen Kao, Tsung‐Wen Chen, Shu‐Chaou Chao, Peter Mu‐Hsin Chang, Chun‐Yu Liu, Cheng‐Hwai Tzeng, Yee Chao, Ming‐Han Chen, Chun‐Nan Yeh, Chi‐Ying F. Huang. Gene expression‐based chemical genomics identifies heat‐shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma. Cancer 2013; 119(2): 293 doi: 10.1002/cncr.27743
|
| 7 |
Chun-Nan Yeh, Kun-Chun Chiang, Horng-Heng Juang, Jong-Hwei S. Pang, Chung-Shan Yu, Kun-Ju Lin, Ta-Sen Yeh, Yi-Yin Jan, Luis Eduardo M. Quintas. Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma. PLoS ONE 2013; 8(7): e69928 doi: 10.1371/journal.pone.0069928
|